Heart failure & cardiomyopathiesCohort study

Association of Charlson Comorbidity Index with Clinical Characteristics and Outcomes in Heart Failure

ESC Heart FailPublished

  • registry study
  • Swedish heart failure (HF) registry
  • multivariable multinominal and Cox regressions

Authors' conclusion

The ACCI discriminates well in HF, with higher ACCI being associated with greater severity of HF, lesser GDMT use and worse quality of life. Higher ACCI was more strongly associated with death than hospitalization. Higher ACCI was more strongly associated with non-CV outcomes but also with CV and HF outcomes.

Study context

Population
Patients with heart failure in the Swedish HF registry
Participants
117,419 patients
Exposure
intermediate and high vs low ACCI

Main finding

As reported in the abstract

Composite CV mortality/first HF hospitalization · up to 3 years
Each group vs low ACCIAdjusted hazard ratio (95% CI)
intermediate ACCI
1.34(1.29–1.39)
high ACCI
1.76(1.69–1.83)

Observational data: associations, not effects.

Further findings

OutcomeEstimate
Non-CV mortalityadjusted HR 6.36 (95% CI 5.75–7.04)
CV mortalityHR 4.35 (CI 3.99–4.74)
Total hospitalizationsadjusted IRR 2.16 (CI 2.11–2.22)
OutcomeEstimate
HF hospitalizations1.23 (CI 1.17–1.28)

Median ACCI by ejection fraction (EF) category

Median ACCI in HFrEF (53% of patients)
5
Median ACCI in HFmrEF (24% of patients)
6
Median ACCI in HFpEF (23% of patients)
6
ACCI ≥7 in HFrEF
31%
ACCI ≥7 in HFmrEF
35%
ACCI ≥7 in HFpEF
42%

Clinical characteristics and guideline-directed medical therapy (GDMT) use

Higher ACCI associated with higher EF category, NYHA class, serum NT-proBNP, diuretic use, and lower quality of life and GDMT use
P < 0.05 for all

Original publication

Association of Charlson Comorbidity Index with Clinical Characteristics and Outcomes in Heart Failure. ESC Heart Fail. Published 19 July 2026. doi:10.1093/eschf/xvag165

Summarised from the published abstract; every number is checked against it